Skye Bioscience to Participate in Upcoming Investment Conferences
Provided By GlobeNewswire
Last update: May 22, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will participate in the following upcoming healthcare conferences:
Read more at globenewswire.com
